BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maru Y, Hippo Y. Two-Way Development of the Genetic Model for Endometrial Tumorigenesis in Mice: Current and Future Perspectives. Front Genet 2021;12:798628. [PMID: 34956336 DOI: 10.3389/fgene.2021.798628] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Murphy AR, Campo H, Kim JJ. Strategies for modelling endometrial diseases. Nat Rev Endocrinol 2022;18:727-43. [PMID: 36050476 DOI: 10.1038/s41574-022-00725-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Navaridas R, Vidal-sabanés M, Ruiz-mitjana A, Perramon-güell A, Megino-luque C, Llobet-navas D, Matias-guiu X, Egea J, Encinas M, Bardia L, Colombelli J, Dolcet X. Transient and DNA-free in vivo CRISPR/Cas9 genome edition for flexible modelling of endometrial carcinogenesis.. [DOI: 10.1101/2022.06.17.496593] [Reference Citation Analysis]
3 Sahoo SS, Ramanand SG, Gao Y, Abbas A, Kumar A, Cuevas IC, Li HD, Aguilar M, Xing C, Mani RS, Castrillon DH. FOXA2 suppresses endometrial carcinogenesis and epithelial-mesenchymal transition by regulating enhancer activity. J Clin Invest 2022;132:e157574. [PMID: 35703180 DOI: 10.1172/JCI157574] [Cited by in F6Publishing: 1] [Reference Citation Analysis]